June 08, 2021

Southeastern Pennsylvania Transportation Authority v. ChemoCentryx, Inc. et al

Track this case

Case Number:

3:21-cv-04357

See also:

Court:

California Northern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Haywood S Gilliam, Jr

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 09, 2021

    ChemoCentryx Hit With Investor Suit Over Drug Trial Claims

    ChemoCentryx Inc. has been hit with a proposed investor class action in California federal court accusing the biopharmaceutical company of overstating the efficacy of its newly developed treatment for an autoimmune disease called ANCA vasculitis.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!